NCT02270489View on ClinicalTrials.gov

Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSA

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 11, 2014

Primary Completion Date

April 18, 2017

Study Completion Date

April 18, 2017

Conditions
Multiple System AtrophyNeurodegenerative Diseases
Interventions
BIOLOGICAL

AFFITOPE® PD01A + Adjuvant

s.c. injection

BIOLOGICAL

AFFITOPE® PD03A + Adjuvant

s.c. injection

BIOLOGICAL

Adjuvant without active component

s.c. injection

Trial Locations (2)

31059

University Hospital Toulouse, Toulouse

33076

University Hospital Bordeaux (Pellegrin Hospital), Bordeaux

All Listed Sponsors
collaborator

University Hospital, Bordeaux

OTHER

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

collaborator

Forschungszentrum Juelich

OTHER

collaborator

University Hospital, Toulouse

OTHER

lead

Affiris AG

INDUSTRY

NCT02270489 - Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSA | Biotech Hunter | Biotech Hunter